Avila Therapeutics' Acquisition

Avila Therapeutics was acquired by Celgene on January 29, 2012.

Avila Therapeutics is developing new medicines that achieve 'protein silencing' based on the proprietary Avilomics platform. Per the company, these medicines, called covalent drugs, strongly and resil…

Articles about Avila Therapeutics' Acquisition: